Prothena Corporation plc (PRTA) financial statements (2021 and earlier)

Company profile

Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
DUBLIN 2, D02 T804
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments295376428418387371294
Cash and cash equivalents295376428418387371294
Restricted cash and investments1      
Receivables0000012
Other current assets 3     
Other undisclosed current assets3 48464
Total current assets:299378431426391377299
Noncurrent Assets
Operating lease, right-of-use asset1823
Property, plant and equipment3453555643
Restricted cash and investments13 44  
Deferred income tax assets12 
Other noncurrent assets011321 
Other undisclosed noncurrent assets 10148632
Total noncurrent assets:344167706985
TOTAL ASSETS:333419499496460385304
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities412141359
Accounts payable411141355
Accrued liabilities      1
Employee-related liabilities      3
Taxes payable00000 0
Debt 5     
Restructuring reserve  0    
Other liabilities7669955
Other undisclosed current liabilities1567141913(2)
Total current liabilities:26181537412212
Noncurrent Liabilities
Long-term debt and lease obligation1218     
Operating lease, liability1218
Liabilities, other than long-term debt11111110222
Deferred revenue and credits0222
Accounts payable and accrued liabilities    000
Deferred revenue110110
Deferred rent credit  0
Other liabilities111  0 
Other undisclosed noncurrent liabilities  1605251  
Total noncurrent liabilities:123129161525322
Total liabilities:14914617689952514
Stockholders' equity
Stockholders' equity attributable to parent184273323407365361290
Common stock0000000
Additional paid in capital967944921849654489338
Accumulated deficit(783)(672)(598)(442)(289)(129)(48)
Total stockholders' equity:184273323407365361290
TOTAL LIABILITIES AND EQUITY:333419499496460385304

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Sublease income33
Gross profit:311281251
Operating expenses(114)(87)(160)(183)(161)(82)(58)
Other undisclosed operating loss(2)      
Operating loss:(113)(86)(159)(155)(160)(80)(7)
Nonoperating income (expense)183(2)100
Investment income, nonoperating     00
Other nonoperating income (expense)(0)00(2)0(0)0
Loss from continuing operations before income taxes:(111)(77)(156)(158)(159)(80)(6)
Income tax expense (benefit)0(0)04(1)(1)(1)
Net loss available to common stockholders, diluted:(111)(78)(156)(153)(160)(81)(7)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(111)(78)(156)(153)(160)(81)(7)
Comprehensive loss, net of tax, attributable to parent:(111)(78)(156)(153)(160)(81)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: